Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Placebo or Control
DRUG
2 trials
Sponsors
The University of Texas Medical Branch, Galveston
, Aldena Therapeutics
Conditions
Alopecia Areata (AA)
Burns
Phase 1
A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
Recruiting
NCT06826196
Aldena Therapeutics
Alopecia Areata (AA)
Start: 2025-03-24
End: 2026-12-01
Target: 24
Updated: 2026-03-04
Phase 2
Assessment of Mechanisms of Improved Wound Healing
Completed
NCT00673309
The University of Texas Medical Branch, Galveston
Burns
Start: 2000-07-31
End: 2013-04-30
Updated: 2023-07-03
Related Papers
The effect of ketoconazole on post-burn inflammation, hypermetabolism and clinical outcomes.
2012-05-11
22 citations
The use of exenatide in severely burned pediatric patients.
2010-08-11
36 citations
Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial.
2010-04-15
142 citations